Primary hyperparathyroidism (HPT) is caused by enlargement of one or more of the 4 parathyroid glands in the neck. The glands become overactive and too much parathyroid hormone is released, which raises the level of calcium in your blood. High levels of calcium in the blood can cause multiple problems including appetite loss, thirst, tiredness, vomiting, nausea, memory loss and depression, among other things.
At present, the only cure for primary HPT is surgical removal of the glands (parathyroidectomy). However, not all patients can have this surgery. The purpose of this study is to evaluate a medication to treat primary hyperpararthyroidism for those who may not be candidates for surgery.
To learn more about this program and to see if you may qualify to participate, contact South Florida Medical Research at Info@southfloridamedicalresearch.com or see the enrollment tab on this site.
All study-related medication and care is provided to you at no cost.
No insurance is needed.
Specific medical requirements must be met for inclusion into this and all clinical studies.